Site Injection Reaction, Maculopapular Rash, and Rosacea Exacerbation after COVID-19 Vaccination

To date, the occurrence of adverse events following immunization after COVID-19 vaccine is rare, and their report is still very poor; however, causality assessment is conducted to identify the associated cause, if they occur. In this case report, we present a case of an association of three cutaneou...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Case reports in dermatological medicine 2022-04, Vol.2022, p.9944727-5
Hauptverfasser:	Benyamna, Younes, Marraha, Farah, Al Faker, Ibtissam, Chahoub, Hanane, Rahmani, Najlae, Rkiek, Yasmine, Kabbou, Soukayna, Soussi Tanani, Driss, Gallouj, Salim
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenoviruses Antigens Case Report Case reports Clinical trials Complications and side effects Coronaviruses COVID-19 vaccines Dermatology Disease transmission Drug dosages Erythema Metronidazole Pandemics Pathogenesis Pharmaceutical industry Pharmacovigilance Proteins Public health Rash (Dermatology) Rosacea Severe acute respiratory syndrome coronavirus 2 Surveillance Vaccination Viral infections Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To date, the occurrence of adverse events following immunization after COVID-19 vaccine is rare, and their report is still very poor; however, causality assessment is conducted to identify the associated cause, if they occur. In this case report, we present a case of an association of three cutaneous manifestations (maculopapular exanthem with enanthem, site injection reaction, and rosacea exacerbation) occurring three days after taking the first dose of AstraZeneca AZD1222 vaccine.
ISSN:	2090-6463 2090-6471
DOI:	10.1155/2022/9944727